arrow_back Back Filing freshness 10-Q Q3 FY2024 SEC EDGAR

VERDE BIO HOLDINGS, INC.

APHD
Price unavailable
Energy ·Crude Petroleum & Natural Gas ·USCrude Petroleum & Natural Gas
53 Visible periods
26 Metrics
Peer-ranked Benchmarks
Price Chart
28
Health
Poor
Bearish
auto_awesome

Analytical Summary

VERDE BIO HOLDINGS, INC. faces fundamental challenges with weakness in Return on Common Equity (%). The fundamentals warrant careful consideration of downside risks.

Market Cap
Dividend Yield
Revenue Growth None
Op. Margin
ROIC -272.5%
FCF / Share $-0.00
Trailing P/E
Price / Book
FCF Yield
Debt / Equity
info Valuation on last close.

53-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$2.32K
Net Income Profit after all expenses
$-1.49M
↓ -239.5%
FCF / Share Free cash flow per share
$-0.00
↑ +24.5%
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Returns
9
Cash Quality
74

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 13 years · 53 quarters